Page 7 - 2020_02-Haematologica-web

haematologica Journal of the Ferrata Storti Foundation
358 Genome analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki Masataka Taguchi et al.
Myeloproliferative Neoplasms
366 Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis Georg Greiner et al.
Myeloid Neoplasms
Myelodysplastic Syndromes
375 Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis Veronica Caraffini et al.
Chronic Myeloid Leukemia
387 Validation of a Drosophila model of wild-type and T315I mutated BCR-ABL1 in chronic myeloid leukemia: an effective platform for treatment screening
Amani Al Outa et al.
Acute Myeloid Leukemia
398 Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemia
Chetasi Talati et al.
407 Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: young HLA-matched unrelated or haploidentical donor?
Miguel-Angel Perales et al.
414 Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMT
Xavier Poiré et al.
Non-Hodgkin Lymphoma
424 MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis Joost S. Vermaat et al.
435 High activation of STAT5A drives peripheral T-cell lymphoma and leukemia Barbara Maurer et al.
Chronic Lymphocytic Leukemia
448 Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia Fary Diop et al.
Plasma Cell Disorders
457 Sialyltransferase inhibition leads to inhibition of tumor cell interactions with E-selectin, VCAM1, and MADCAM1, and improves survival in a human multiple myeloma mouse model
Alessandro Natoni et al.
468 Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies
Maria-Victoria Mateos et al.
Complications in Hematology
478 Ibrutinib induces multiple functional defects in the neutrophil response against Aspergillus fumigatus Damien Blez et al.
Hemostasis
490 Increased incidence of cancer in the follow-up of obstetric antiphospholipid syndrome within the NOH-APS cohort Jean-Christophe Gris et al.
Haematologica 2020; vol. 105 no. 2 - February 2020 http://www.haematologica.org/